Recombinant Humanized Anti-IL-36R Monoclonal antibody and Placebo
HB0034-03
Phase 1 small_molecule completed
Quick answer
Recombinant Humanized Anti-IL-36R Monoclonal antibody and Placebo for Healthy is a Phase 1 program (small_molecule) at Shanghai University of Traditional Chinese Medicine with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Shanghai University of Traditional Chinese Medicine
- Indication
- Healthy
- Phase
- Phase 1
- Modality
- small_molecule
- Status
- completed